Ceballos Medina, Ana
Gómez-Acebo, Inés
Gallego de Largy, Cristina Clare
Alonso-Molero, Jessica
Vilares Calvo, Silvia
Odriozola Feu, Juan Manuel
Ceballos Medina, María
Dierssen-Sotos, Trinidad
Article History
Received: 19 February 2025
Accepted: 29 May 2025
First Online: 4 June 2025
Declarations
:
: This project was approved by the Ethics Committee for Clinical Research of Cantabria (Comité de Ética de la Investigación con Medicamentos de Cantabria, CEIm) on 01/12/2022, reference number 2022.237. The study was conducted as an observational study, collecting data from medical records without any direct intervention on participants, and therefore, no risks were associated with participation. In accordance with Royal Decree 957/2020, which regulates observational studies in Spain, a waiver of informed consent was requested and granted by the Ethics Committee. The processing, communication, and transfer of personal data complied with all applicable regulations, including the General Data Protection Regulation (GDPR, Regulation (EU) 2016/679 of the European Parliament and of the Council, April 27, 2016) and the Spanish Organic Law 3/2018, of December 5, on Personal Data Protection and Guarantee of Digital Rights. The study adhered to Spanish laws on biomedical research, European Union data protection regulations, and the Declaration of Helsinki on ethical principles for medical research involving human subjects.
: Not applicable.
: The authors declare no competing interests.